Guidelines for the management of drug clinical trials during COVID-19 epidemic (on a trial basis)

China (National)

Issuing Authority: Center for Drug Evaluation, National Medical Products Administration

Type: Law/Policy Document

July 14, 2020 (issued)

Download Law/Policy Document